Authors: CLAYMAN GL ELNAGGAR AK LIPPMAN SM HENDERSON YC FREDERICK M MERRITT JA ZUMSTEIN LA TIMMONS TM LIU TJ GINSBERG L ROTH JA HONG WK BRUSO P GOEPFERT H

Citation: Gl. Clayman et al., ADENOVIRUS-MEDIATED P53 GENE-TRANSFER IN PATIENTS WITH ADVANCED RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Journal of clinical oncology, 16(6), 1998, pp. 2221-2232

Authors: ROTH JA SWISHER SG MERRITT JA LAWRENCE DD KEMP BL CARRASCO CH ELNAGGAR AK FOSSELLA FV GLISSON BS HONG WK KHURL FR KURIE JM NESBITT JC PISTERS K PUTNAM JB SCHRUMP DS SHIN DM WALSH GL

Citation: Ja. Roth et al., GENE-THERAPY FOR NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT OF A PHASE-I TRIAL OF ADENOVIRAL P53 GENE REPLACEMENT, Seminars in oncology, 25(3), 1998, pp. 33-37

Authors: MERRITT JA CLAYMAN GL SWISHER S NEMUNAITIS J ELNAGGAR A GINSBERG L LAWRENCE D TIMMONS T HENDERSON Y FREDERICK M CONNORS D HUTCHISON A BRUSO P ROTH JA SHULKIN A WEILL D WAIT J

Citation: Ja. Merritt et al., CLINICAL-PHASE-I EXPERIENCE WITH INGN-201 (AD-P53) IN NONSMALL CELL LUNG-CANCER AND HEAD AND NECK-CANCER, Cancer gene therapy, 4(6), 1997, pp. 1-1

Authors: MERRITT JA CLAYMAN G SCHWISHER S NEMUNAITIS J ELNAGGAR A TIMMONS T LAWRENCE D KEMP B FREDERICK M CONNORS D BRUSO P GOEPFERT H HONG WK ROTH JA

Citation: Ja. Merritt et al., CLINICAL GENE-THERAPY STRATEGIES - PHASE-I PHASE-II RESULTS WITH ADENOVIRAL P53 (INGN-201) GENE-TRANSFER IN ADVANCED HEAD AND NECK AND NON-SMALL-CELL LUNG CANCERS/, Cancer gene therapy, 4(5), 1997, pp. 330-330

Authors: QUAN WDY DEAN GE SPEARS L SPEARS CP GROSHEN S MERRITT JA MITCHELL MS

Citation: Wdy. Quan et al., ACTIVE SPECIFIC IMMUNOTHERAPY OF METASTATIC MELANOMA WITH AN ANTIIDIOTYPE VACCINE - A PHASE I II TRIAL OF I-MEL-2 PLUS SAF-M/, Journal of clinical oncology, 15(5), 1997, pp. 2103-2110

Authors: LEGER DW THOMPSON RA MERRITT JA BENZ JJ

Citation: Dw. Leger et al., ADULT PERCEPTION OF EMOTION INTENSITY IN HUMAN INFANT CRIES - EFFECTSOF INFANT AGE AND CRY ACOUSTICS, Child development, 67(6), 1996, pp. 3238-3249